National Center for Advancing Translational Sciences; Notice of Meeting, 49664-49665 [2020-17858]
Download as PDF
<![CDATA[
49664
Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV–2) and
Coronavirus Disease 2019 (COVID–19).
Date: September 4, 2020
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Jennifer H. Meyers, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, MSC–9823, Rockville, MD
20852, 301–761–6602, jennifer.meyers@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 11, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17861 Filed 8–13–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases (NIAID)
Special Emphasis Panel NIAID Investigator
Initiated Program Project Applications (P01).
Date: October 20, 2020.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:29 Aug 13, 2020
Jkt 250001
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G41,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Kelly L. Hudspeth, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, MSC–
9823, Rockville, MD 20852, 240–669–5067,
kelly.hudspeth@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 11, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17860 Filed 8–13–20; 8:45 am]
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: August 11, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17862 Filed 8–13–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center for Advancing
Translational Sciences; Notice of
Meeting
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel: Mechanism for Time
Sensitive Research Opportunities in
Environmental Health Sciences.
Date: September 3, 2020.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Science, Keystone Building, 530 Davis
Drive, Durham, NC 27709 (Virtual Meeting).
Contact Person: Janice B Allen, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Science, P.O. Box 12233, MD EC–30/
Room 3170 B, Research Triangle Park, NC
27709, 984–287–3232, allen9@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Center for
Advancing Translational Sciences
Advisory Council.
The meeting will be open to the
public as indicated below, viewing
virtually by WebEx. Individuals can
register to view and access the meeting
by the links below:
September 17, 2020 WebEx: https://
nih.webex.com/nih/onstage/
g.php?MTID=ec5429a67a
9f4966244b7335797c7f08b.
September 18, 2020 WebEx: https://
nih.webex.com/nih/onstage/
g.php?MTID=e7326f004e32dc19cccaad
8405367464b.
1. Go to ‘‘Event Status’’ on the lefthand side of page, then click ‘‘Register’’.
On the registration form, enter your
information and then click ‘‘Submit’’ to
complete the required registration.
2. You will receive a personalized
email with the live event link.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices
Date: September 17–18, 2020.
Closed: September 17, 2020, 11:00 a.m. to
12:30 p.m.
Agenda: To discuss internal operations,
review and evaluate grant applications.
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Open: September 17, 2020, 1:00 p.m. to
3:00 p.m.
Agenda: To view and discuss Clearance of
Concepts.
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Open: September 18, 2020, 11:00 a.m. to
3:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health, One
Democracy Plaza, 9th Floor, Conference
Rooms 987/989, 6701 Democracy Boulevard,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 11, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17858 Filed 8–13–20; 8:45 am]
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
Jkt 250001
Dated: August 11, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–17839 Filed 8–13–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:29 Aug 13, 2020
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel and Translational Science
Awards (CTSA) Review.
Date: September 9–10, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1080, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victor Henriquez, Ph.D.,
Scientific Review Officer, Office of Scientific
Director, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4878, 301–435–0813, henriquv@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
VerDate Sep<11>2014
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via web
conference on September 1st, 2020,
from 10:00 a.m. EDT to 5:30 p.m. EDT.
The board will meet in open-session
September 1st, 2020, from 10:00 a.m.
EDT to 1:00 p.m. EDT to discuss the
Mandatory Guidelines for Federal
Workplace Drug Testing Programs with
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
49665
updates from the Department of
Transportation and the Nuclear
Regulatory Commission. Other
discussion topic include an update on
marijuana studies and efforts. The board
will meet in closed-session on
September 1st, 2020, from 2:00 p.m.
EDT to 5:30 p.m. EDT to discuss
confidential issues surrounding the
proposed Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (hair), preliminary and
unpublished studies from the Johns
Hopkins University Behavioral
Pharmacology Research Unit (BPRU),
additional drugs (fentanyl and
methadone) that may be tested for in the
future, and lastly, emerging issues on
marijuana. Therefore, the portion of the
meeting on September 1st, 2020, from
2:00 p.m. EDT to 5:30 p.m. EDT, is
closed to the public, as determined by
the Assistant Secretary for Mental
Health and Substance Use, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(4) and
(9)(B), and 5 U.S.C. App. 2, Section
10(d).
Meeting registration information can
be completed at https://
snacregister.samhsa.gov/
MeetingList.aspx. Web conference and
call information will be sent after
completing registration. Meeting
information and a roster of DTAB
members may be obtained by accessing
the SAMHSA Advisory Committees
website, https://www.samhsa.gov/
about-us/advisory-councils/meetings or
by contacting the Designated Federal
Officer, Jennifer Fan.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: September 1, 2020,
from 10:00 a.m. to 1:00 p.m. EDT:
OPEN. September 1, 2020, from 2:00
p.m. to 5:30 p.m. EDT: CLOSED.
Place: Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857.
Contact: Jennifer Fan, Senior
Pharmacist, Center for Substance Abuse
Prevention, 5600 Fishers Lane, Room
16N06D, Rockville, Maryland 20857,
Telephone: (240) 276–1759, Email:
jennifer.fan@samhsa.hhs.gov.
Anastasia Marie Donovan,
Policy Analyst.
[FR Doc. 2020–17789 Filed 8–13–20; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Pages 49664-49665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17858]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Center for
Advancing Translational Sciences Advisory Council.
The meeting will be open to the public as indicated below, viewing
virtually by WebEx. Individuals can register to view and access the
meeting by the links below:
September 17, 2020 WebEx: https://nih.webex.com/nih/onstage/g.php?MTID=ec5429a67a9f4966244b7335797c7f08b.
September 18, 2020 WebEx: https://nih.webex.com/nih/onstage/g.php?MTID=e7326f004e32dc19cccaad8405367464b.
1. Go to ``Event Status'' on the left-hand side of page, then click
``Register''. On the registration form, enter your information and then
click ``Submit'' to complete the required registration.
2. You will receive a personalized email with the live event link.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Advisory Council.
[[Page 49665]]
Date: September 17-18, 2020.
Closed: September 17, 2020, 11:00 a.m. to 12:30 p.m.
Agenda: To discuss internal operations, review and evaluate
grant applications.
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: September 17, 2020, 1:00 p.m. to 3:00 p.m.
Agenda: To view and discuss Clearance of Concepts.
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Open: September 18, 2020, 11:00 a.m. to 3:00 p.m.
Agenda: Report from the Institute Director and other staff.
Place: National Institutes of Health, One Democracy Plaza, 9th
Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive
Secretary, National Center for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: August 11, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-17858 Filed 8-13-20; 8:45 am]
BILLING CODE 4140-01-P
